Category supply reports
The registration data for each therapeutic category Ogbogwu tracks — who holds the registrations, where the products are made, what was newly approved and what comes due for renewal. Every number is quoted from our October 2026 copy of the NAFDAC Greenbook and recomputed with each monthly register refresh.
Antibiotics
819 active registrations from 304 companies, across 16 molecules.
48 new in 12 months · 175 renewals due within a year
Read the report →Pain & Fever
685 active registrations from 292 companies, across 11 molecules.
54 new in 12 months · 82 renewals due within a year
Read the report →Antimalarials
449 active registrations from 234 companies, across 8 molecules.
46 new in 12 months · 42 renewals due within a year
Read the report →Hypertension
284 active registrations from 120 companies, across 12 molecules.
26 new in 12 months · 47 renewals due within a year
Read the report →Dermatology
273 active registrations from 109 companies, across 7 molecules.
10 new in 12 months · 18 renewals due within a year
Read the report →Vitamins & Supplements
173 active registrations from 85 companies, across 9 molecules.
3 new in 12 months · 21 renewals due within a year
Read the report →Digestive Health
162 active registrations from 106 companies, across 7 molecules.
6 new in 12 months · 31 renewals due within a year
Read the report →Diabetes
137 active registrations from 51 companies, across 10 molecules.
8 new in 12 months · 18 renewals due within a year
Read the report →Allergy
115 active registrations from 78 companies, across 5 molecules.
4 new in 12 months · 19 renewals due within a year
Read the report →Respiratory
104 active registrations from 78 companies, across 3 molecules.
5 new in 12 months · 21 renewals due within a year
Read the report →Eye & Ear Drops
77 active registrations from 49 companies, across 3 molecules.
7 new in 12 months · 9 renewals due within a year
Read the report →Sexual Health
58 active registrations from 42 companies, across 2 molecules.
4 new in 12 months · 11 renewals due within a year
Read the report →Antifungals
53 active registrations from 43 companies, across 2 molecules.
8 new in 12 months · 3 renewals due within a year
Read the report →Cholesterol
51 active registrations from 31 companies, across 3 molecules.
10 new in 12 months · 12 renewals due within a year
Read the report →Antiparasitics
39 active registrations from 28 companies, across 4 molecules.
1 new in 12 months · 7 renewals due within a year
Read the report →Cough, Cold & Flu
37 active registrations from 25 companies, across 4 molecules.
2 new in 12 months · 4 renewals due within a year
Read the report →Blood Thinners
36 active registrations from 32 companies, across 3 molecules.
4 new in 12 months · 3 renewals due within a year
Read the report →Epilepsy
25 active registrations from 19 companies, across 3 molecules.
3 new in 12 months · 0 renewals due within a year
Read the report →Each report states its scope — the molecules it counts — because the register itself has no therapeutic grouping. Registration data is not market-share or sales data; for decisions that matter, confirm on the official Greenbook.